Profile data is unavailable for this security.
About the company
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business to business-to-consumer. It operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands: +PlusCBD and Cultured Foods in the healthcare market sector: nutraceutical, beauty care, specialty foods, and pet products. +PlusCBD branded products are sold at select retail locations throughout the United States. Cultured Foods brand provides a variety of plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience. It manufactures encapsulated softgels and tinctures for the supplement and nutrition industry.
- Revenue in USD (TTM)15.86m
- Net income in USD-3.23m
- Incorporated2013
- Employees42.00
- LocationCV Sciences Inc9530 PADGETT STREET, SUITE 107SAN DIEGO 92126United StatesUSA
- Fax+1 (619) 876-4321
- Websitehttps://cvsciences.com/
Mergers & acquisitions
| Acquired company | CVSI:QBB since announced | Transaction value |
|---|---|---|
| Cultured Foods Sp z o o | 70.00% | 568.00k |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Monopar Therapeutics Inc | 0.00 | -7.61m | 10.68m | 10.00 | -- | 1.43 | -- | -- | -0.5289 | -0.5289 | 0.00 | 0.4277 | 0.00 | -- | -- | 0.00 | -73.36 | -54.07 | -92.67 | -60.60 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 20.10 | -- | -- | -- |
| Scorpius Holdings Inc | 9.74m | -32.20m | 10.73m | 82.00 | -- | 0.1399 | -- | 1.10 | -1.22 | -1.40 | 0.3663 | 0.7937 | 0.1372 | -- | 26.56 | 118,815.70 | -47.81 | -39.37 | -58.20 | -43.18 | 68.56 | -- | -348.43 | -1,068.21 | 0.2641 | -198.18 | 0.3179 | -- | 1,789.58 | 3.84 | 1.96 | -- | 27.32 | -- |
| Vaccinex Inc | 124.00k | -19.19m | 10.74m | 37.00 | -- | 7.57 | -- | 86.63 | -46.02 | -46.02 | 0.1685 | 1.68 | 0.0202 | -- | 0.0894 | 3,351.35 | -312.93 | -262.29 | -731.45 | -- | -- | -- | -15,472.58 | -4,257.17 | -- | -55.90 | 0.03 | -- | 107.27 | -4.67 | -2.20 | -- | -22.20 | -- |
| Medical Marijuana Inc | -100.00bn | -100.00bn | 10.80m | -- | -- | 0.0999 | -- | -- | -- | -- | -- | 0.019 | -- | -- | -- | -- | -- | -22.66 | -- | -23.11 | -- | 70.58 | -- | -145.52 | 1.79 | -- | 0.0479 | -- | 26.30 | 39.07 | 141.59 | -- | -0.016 | -- |
| Allarity Therapeutics Inc | 0.00 | -20.94m | 10.85m | 5.00 | -- | -- | -- | -- | -599.34 | -599.34 | 0.00 | -18.88 | 0.00 | -- | -- | 0.00 | -100.46 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.02 | -- | -- | -- |
| Ayala Pharmaceuticals Inc | 13.00k | -48.07m | 10.91m | 20.00 | -- | -- | -- | 839.55 | -7.46 | -7.46 | 0.0022 | -2.06 | -- | -- | -- | 650.00 | -- | -- | -- | -- | 0.00 | -- | -369,784.60 | -- | -- | -2.31 | -- | -- | -- | -- | -- | -- | -- | -- |
| Bon Natural Life Ltd | 29.52m | 4.60m | 10.92m | 96.00 | 0.5511 | 0.091 | 1.98 | 0.3699 | 4.99 | 4.99 | 32.10 | 30.23 | 0.7045 | 15.27 | 5.19 | 307,524.60 | 10.86 | 14.04 | 13.69 | 20.68 | 29.94 | 30.00 | 15.42 | 17.62 | 2.41 | 30.54 | 0.0955 | 0.00 | -1.29 | 22.32 | -26.32 | 83.09 | -6.70 | -- |
| Moleculin Biotech Inc | 0.00 | -26.82m | 11.03m | 18.00 | -- | 0.5108 | -- | -- | -12.94 | -12.94 | 0.00 | 9.34 | 0.00 | -- | -- | 0.00 | -65.50 | -46.84 | -75.07 | -51.49 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -2.56 | -- | -21.54 | -- |
| CV Sciences Inc | 15.86m | -3.23m | 11.10m | 42.00 | -- | 4.70 | -- | 0.6999 | -0.0207 | -0.0207 | 0.1012 | 0.0145 | 1.59 | 1.42 | 27.25 | 377,571.40 | -32.43 | -43.42 | -83.71 | -77.75 | 45.13 | 51.81 | -20.38 | -45.68 | 0.2677 | -13.32 | 0.0472 | -- | -1.24 | -19.80 | 133.96 | -20.87 | -- | -- |
| Galera Therapeutics Inc | 0.00 | -45.75m | 11.70m | 7.00 | -- | -- | -- | -- | -0.9971 | -0.9971 | 0.00 | -2.48 | 0.00 | -- | -- | 0.00 | -115.30 | -83.69 | -142.79 | -97.54 | -- | -- | -- | -- | -- | -6.49 | 9.23 | -- | -- | -- | 5.05 | -- | -29.84 | -- |
| Transcode Therapeutics Inc | 0.00 | -17.06m | 11.75m | 10.00 | -- | 2.25 | -- | -- | -206.36 | -206.36 | 0.00 | 0.7893 | 0.00 | -- | -- | 0.00 | -264.82 | -133.14 | -721.90 | -181.26 | -- | -- | -- | -- | -- | -148.05 | 0.00 | -- | -- | -- | -5.59 | -- | -- | -- |
| Enzolytics Inc | 0.00 | -119.19k | 11.80m | 2.00 | -- | -- | -- | -- | -0.106 | -0.106 | 0.00 | -1.04 | 0.00 | -- | -- | -- | -369.52 | -- | -- | -- | -- | -- | -- | -- | -- | -4.30 | -- | -- | -100.00 | -- | -9.35 | -- | -- | -- |
| Sunshine Biopharma Inc | 26.74m | -4.09m | 11.87m | 44.00 | -- | 0.0251 | -- | 0.4439 | -13.35 | -13.35 | 76.96 | 24.96 | 0.9081 | 3.13 | 11.58 | 607,722.50 | -13.88 | -101.52 | -17.99 | -137.04 | 33.15 | 35.47 | -15.29 | -165.33 | 3.23 | -- | 0.00 | -- | 454.42 | -- | 83.15 | -- | 110.99 | -- |
| Holder | Shares | % Held |
|---|---|---|
| MML Investors Services LLCas of 31 Mar 2024 | 5.00k | 0.00% |
| TriVant Custom Portfolio Group LLCas of 31 Mar 2024 | 0.00 | 0.00% |
